Fukusaki M, Matsumoto M, Yamaguchi K, Ogata K, Ide R, Sumikawa K
Department of Anesthesiology, Nagasaki Rosai Hospital, Japan.
J Clin Anesth. 1996 Nov;8(7):545-50. doi: 10.1016/s0952-8180(96)00119-5.
To evaluate the effects of hemodilution during controlled hypotension on, the hepatic renal, and pancreatic function in the clinical setting.
Randomized, prospective study.
Inpatient surgery at Rosai Hospital.
20 ASN status I and II patients scheduled for total hip arthroplasty.
Hemodilution was carried out after induction of anesthesia, in which drawn blood was replaced with dextran solution to achieve final hematocrit (Hct) of 31% Group A = mild hemodilution group, N = 10) or 23% (Group B = moderate hemodilution group, N = 10). In both groups, controlled hypotension was induced with prostaglandin in (PGE1) to maintain mean arterial blood pressure at 55 mm Hg for 80 minutes.
Measurements included arterial ketone body ratio AKBR, aceto-acetate/3-hydroxybutyrate) for hepatic cellular function, pancreatic phospholipase A2 (P-PLA2) for pancreatic cellular function, and urine N-acetyl-beta-D-glucosaminidase (NAG index) for cellular function of the renal tubule. These indices were measured before hemodilution, after hemodilution, 80 minutes after starting hypotension, 60 minutes after recovery of normotension, and on the first postoperative day. Neither AKBR nor P-PLA2 showed a significant change throughout the time course of the study in either group. Urine-NAG index showed a significant increase in moderate hemodilution group at 60 minutes after recovery of normotension (+ 136%) and on the first postoperative lay (+ 149%) compared with prehemodilution value, whereas it showed no significant change in the mild hemodilution group. Blood urea nitrogen and serum creatinine measured postoperatively were within normal range.
PGE1 induced hypotension combined with moderate hemodilution using dextran, such as 23% of Net value maintains hepatic and pancreatic function but causes damage to the renal tubular cells.
评估临床环境中控制性低血压期间血液稀释对肝、肾和胰腺功能的影响。
随机前瞻性研究。
罗萨伊医院的住院手术。
20例计划进行全髋关节置换术的美国麻醉医师协会(ASA)I级和II级患者。
麻醉诱导后进行血液稀释,抽出的血液用右旋糖酐溶液替代,使最终血细胞比容(Hct)达到31%(A组=轻度血液稀释组,N = 10)或23%(B组=中度血液稀释组,N = 10)。两组均用前列腺素E1(PGE1)诱导控制性低血压,将平均动脉血压维持在55 mmHg 80分钟。
测量指标包括用于评估肝细胞功能的动脉酮体比(AKBR,乙酰乙酸/3-羟基丁酸)、用于评估胰腺细胞功能的胰腺磷脂酶A2(P-PLA2)以及用于评估肾小管细胞功能的尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG指数)。这些指标在血液稀释前、血液稀释后、开始低血压80分钟后、恢复正常血压60分钟后以及术后第一天进行测量。在研究的整个时间过程中,两组的AKBR和P-PLA2均未显示出显著变化。与血液稀释前的值相比,中度血液稀释组在恢复正常血压60分钟后(升高136%)和术后第一天(升高149%)尿NAG指数显著升高,而轻度血液稀释组未显示出显著变化。术后测量的血尿素氮和血清肌酐在正常范围内。
PGE1诱导的低血压联合使用右旋糖酐进行中度血液稀释,如净值的23%,可维持肝和胰腺功能,但会导致肾小管细胞损伤。